{"id":"NCT00306787","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes","officialTitle":"A Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Patient-initiated Famciclovir 1000 mg b.i.d. x 1 Day to Valacyclovir 500 mg b.i.d. x 3 Days in Immunocompetent Adults With Recurrent Genital Herpes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2006-03-24","resultsPosted":"2011-06-17","lastUpdate":"2011-06-30"},"enrollment":1179,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Genital Herpes"],"interventions":[{"type":"DRUG","name":"Famciclovir","otherNames":["Famvir"]},{"type":"DRUG","name":"Valacyclovir","otherNames":["Valtrex"]},{"type":"DRUG","name":"Placebo matching famciclovir","otherNames":[]},{"type":"DRUG","name":"Placebo matching valacyclovir","otherNames":[]}],"arms":[{"label":"Famciclovir","type":"EXPERIMENTAL"},{"label":"Valacyclovir","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the safety and efficacy of one-day famciclovir (1000 mg twice a day (b.i.d)) in reducing the duration of genital herpes lesions and the associated symptoms compared to three-day treatment with valacyclovir (500 mg capsule b.i.d).","primaryOutcome":{"measure":"Investigator-assessed Time to Healing of All Non-aborted Genital Herpes Lesions","timeFrame":"72 hours after initiation of study medication up to Day 20","effectByArm":[{"arm":"Famciclovir","deltaMin":4.25,"sd":null},{"arm":"Valacyclovir","deltaMin":4.08,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":66,"countries":["United States","Australia","Canada","Germany"]},"refs":{"pmids":["19192993"],"seeAlso":["http://www.novartisclinicaltrials.com/etrials/searchTrial.do?trialID=520"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":371},"commonTop":["Headache","Nausea","Diarrhea","Vomiting","Abdominal pain"]}}